BlackRock »

Viracta Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Viracta Therapeutics (VIRX) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Viracta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viracta Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viracta Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2024-12-31 $38k 235k 0.16
2024-09-30 $54k 235k 0.23